Skip to main content
Erschienen in: Pituitary 1/2011

01.03.2011

Azathioprine as an alternative treatment in primary hypophysitis

verfasst von: L. Papanastasiou, T. Pappa, V. Tsiavos, E. Tseniklidi, I. Androulakis, G. Kontogeorgos, G. Piaditis

Erschienen in: Pituitary | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Primary hypophysitis (PH) is an unusual disorder characterized by inflammatory infiltration of the pituitary gland with various degree of pituitary dysfunction. Glucocorticoids are the treatment of choice in the majority of patients. Still, in patients with poor response in glucocorticoids or when their administration is accompanied with serious side effects, the use of alternative agents should be considered; up to now, data on other therapeutic approaches remains scant mainly due to the rarity of the disease. Among them, the immunosuppressant azathioprine could represent an effective and safe alternative. In this article, we present our clinical experience of two cases with PH successfully treated with azathioprine following serious side effects after initial treatment with glucocorticoids and provide a brief review of the existing literature.
Literatur
1.
Zurück zum Zitat Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614CrossRefPubMed Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614CrossRefPubMed
2.
Zurück zum Zitat Ahmed SR, Aiello DP, Page R, Hopper K, Towfighi J, Santen RJ (1993) Necrotizing infundibulo-hypophysitis: a unique syndrome of diabetes insipidus and hypopituitarism. J Clin Endocrinol Metab 76:1499–1504CrossRefPubMed Ahmed SR, Aiello DP, Page R, Hopper K, Towfighi J, Santen RJ (1993) Necrotizing infundibulo-hypophysitis: a unique syndrome of diabetes insipidus and hypopituitarism. J Clin Endocrinol Metab 76:1499–1504CrossRefPubMed
3.
Zurück zum Zitat Hama S, Arita K, Tominaga A, Yoshikawa M, Eguchi K, Sumida M, Inai K, Nishisaka T, Kurisu K (1999) Symptomatic Rathke’s cleft cyst coexisting with central diabetes insipidus and hypophysitis: case report. Endocr J 46:187–192CrossRefPubMed Hama S, Arita K, Tominaga A, Yoshikawa M, Eguchi K, Sumida M, Inai K, Nishisaka T, Kurisu K (1999) Symptomatic Rathke’s cleft cyst coexisting with central diabetes insipidus and hypophysitis: case report. Endocr J 46:187–192CrossRefPubMed
4.
Zurück zum Zitat Cheung CC, Ezzat S, Smyth HS, Asa SL (2001) The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab 86:1048–1053CrossRefPubMed Cheung CC, Ezzat S, Smyth HS, Asa SL (2001) The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab 86:1048–1053CrossRefPubMed
5.
Zurück zum Zitat Tashiro T, Sano T, Xu B, Wakatsuki S, Kagawa N, Nishioka H, Yamada S, Kovacs K (2002) Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases. Endocr Pathol 13:183–195CrossRefPubMed Tashiro T, Sano T, Xu B, Wakatsuki S, Kagawa N, Nishioka H, Yamada S, Kovacs K (2002) Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases. Endocr Pathol 13:183–195CrossRefPubMed
6.
Zurück zum Zitat Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Hovarth E, Ezzat S (1995) Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 80:2302–2311CrossRefPubMed Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Hovarth E, Ezzat S (1995) Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 80:2302–2311CrossRefPubMed
7.
Zurück zum Zitat Hashimoto K, Takao T, Makino S (1997) Lymphocytic adenohypophysitis and infundibuloneurohypophysitis. Endocr J 44:1–10CrossRefPubMed Hashimoto K, Takao T, Makino S (1997) Lymphocytic adenohypophysitis and infundibuloneurohypophysitis. Endocr J 44:1–10CrossRefPubMed
8.
Zurück zum Zitat Bevan JS, Othman S, Lazarus JH, Parkes AB, Hall R (1992) Reversible adrenocorticotropin deficiency due to probable autoimmune hypophysitis in a woman with postpartum thyroiditis. J Clin Endocrinol Metab 74:548–552CrossRefPubMed Bevan JS, Othman S, Lazarus JH, Parkes AB, Hall R (1992) Reversible adrenocorticotropin deficiency due to probable autoimmune hypophysitis in a woman with postpartum thyroiditis. J Clin Endocrinol Metab 74:548–552CrossRefPubMed
9.
Zurück zum Zitat Gagneja H, Arafah B, Taylor HC (1999) Histologically proven lymphocytic hypophysitis: spontaneous resolution and subsequent pregnancy. Mayo Clin Proc 74:150–154CrossRefPubMed Gagneja H, Arafah B, Taylor HC (1999) Histologically proven lymphocytic hypophysitis: spontaneous resolution and subsequent pregnancy. Mayo Clin Proc 74:150–154CrossRefPubMed
10.
Zurück zum Zitat Cosman F, Post KD, Holub DA, Wardlaw SL (1989) Lymphocytic hypophysitis. Report of 3 new cases and review of the literature. Medicine (Baltimore) 68:240–256CrossRef Cosman F, Post KD, Holub DA, Wardlaw SL (1989) Lymphocytic hypophysitis. Report of 3 new cases and review of the literature. Medicine (Baltimore) 68:240–256CrossRef
11.
Zurück zum Zitat Lecube A, Francisco G, Rodríguez D, Ortega A, Codina A, Hernández C, Simó R (2003) Lymphocytic hypophysitis succesfully treated with azathioprine: first case report. J Neurol Neurosurg Psychiatry 74:1581–1583CrossRefPubMed Lecube A, Francisco G, Rodríguez D, Ortega A, Codina A, Hernández C, Simó R (2003) Lymphocytic hypophysitis succesfully treated with azathioprine: first case report. J Neurol Neurosurg Psychiatry 74:1581–1583CrossRefPubMed
12.
Zurück zum Zitat Tubridy N, Saunders D, Thom M, Asa SL, Powell M, Plant GT, Howard R (2001) Infundibulohypophysitis in a man presenting with diabetes insipidus and cavernous sinus involvement. J Neurol Neurosurg Psychiatry 71:798–801CrossRefPubMed Tubridy N, Saunders D, Thom M, Asa SL, Powell M, Plant GT, Howard R (2001) Infundibulohypophysitis in a man presenting with diabetes insipidus and cavernous sinus involvement. J Neurol Neurosurg Psychiatry 71:798–801CrossRefPubMed
13.
Zurück zum Zitat Ward L, Paquette J, Seidman E, Huot C, Alvarez F, Crock P, Delvin E, Kämpe O, Deal C (1999) Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 84:844–852CrossRefPubMed Ward L, Paquette J, Seidman E, Huot C, Alvarez F, Crock P, Delvin E, Kämpe O, Deal C (1999) Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 84:844–852CrossRefPubMed
14.
Zurück zum Zitat Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA, De Bellis A (2003) Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol 149:363–376CrossRefPubMed Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA, De Bellis A (2003) Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol 149:363–376CrossRefPubMed
15.
Zurück zum Zitat Rivera JA (2006) Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy. Pituitary 9:35–45CrossRefPubMed Rivera JA (2006) Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy. Pituitary 9:35–45CrossRefPubMed
16.
Zurück zum Zitat Leung GK, Lopes MB, Thorner MO, Vance ML, Laws ER Jr (2004) Primary hypophysitis: a single-center experience in 16 cases. J Neurosurg 101:262–271CrossRefPubMed Leung GK, Lopes MB, Thorner MO, Vance ML, Laws ER Jr (2004) Primary hypophysitis: a single-center experience in 16 cases. J Neurosurg 101:262–271CrossRefPubMed
17.
Zurück zum Zitat Sautner D, Saeger W, Lüdecke DK, Jansen V, Puchner MJ (1995) Hypophysitis in surgical and autoptical specimens. Acta Neuropathol 90:637–644CrossRefPubMed Sautner D, Saeger W, Lüdecke DK, Jansen V, Puchner MJ (1995) Hypophysitis in surgical and autoptical specimens. Acta Neuropathol 90:637–644CrossRefPubMed
18.
Zurück zum Zitat Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK (2003) Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 6:161–168CrossRefPubMed Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK (2003) Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 6:161–168CrossRefPubMed
19.
Zurück zum Zitat Gutenberg A, Hans V, Puchner MJ, Kreutzer J, Brück W, Caturegli P, Buchfelder M (2006) Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol 155:101–107CrossRefPubMed Gutenberg A, Hans V, Puchner MJ, Kreutzer J, Brück W, Caturegli P, Buchfelder M (2006) Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol 155:101–107CrossRefPubMed
20.
Zurück zum Zitat Asa SL, Bilbao JM, Kovacs K, Josse RG, Kreines K (1981) Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: a distinct clinicopathologic entity. Ann Intern Med 95:166–171PubMed Asa SL, Bilbao JM, Kovacs K, Josse RG, Kreines K (1981) Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: a distinct clinicopathologic entity. Ann Intern Med 95:166–171PubMed
21.
Zurück zum Zitat Beressi N, Beressi JP, Cohen R, Modigliani E (1999) Lymphocytic hypophysitis. A review of 145 cases. Ann Med Interne (Paris) 150:327–341 Beressi N, Beressi JP, Cohen R, Modigliani E (1999) Lymphocytic hypophysitis. A review of 145 cases. Ann Med Interne (Paris) 150:327–341
22.
Zurück zum Zitat Tanaka S, Tatsumi KI, Takano T, Murakami Y, Takao T, Yamakita N, Tahara S, Teramoto A, Hashimoto K, Kato Y, Amino N (2003) Anti-alpha-enolase antibodies in pituitary disease. Endocr J 50:697–702CrossRefPubMed Tanaka S, Tatsumi KI, Takano T, Murakami Y, Takao T, Yamakita N, Tahara S, Teramoto A, Hashimoto K, Kato Y, Amino N (2003) Anti-alpha-enolase antibodies in pituitary disease. Endocr J 50:697–702CrossRefPubMed
23.
Zurück zum Zitat De Bellis A, Ruocco G, Battaglia M, Conte M, Coronella C, Tirelli G, Bellastella A, Pane E, Sinisi AA, Bizzarro A, Bellastella G (2008) Immunological and clinical aspects of lymphocytic hypophysitis. Clin Sci (Lond) 114:413–421CrossRef De Bellis A, Ruocco G, Battaglia M, Conte M, Coronella C, Tirelli G, Bellastella A, Pane E, Sinisi AA, Bizzarro A, Bellastella G (2008) Immunological and clinical aspects of lymphocytic hypophysitis. Clin Sci (Lond) 114:413–421CrossRef
24.
Zurück zum Zitat Honegger J, Fahlbusch R, Bornemann A, Hensen J, Buchfelder M, Müller M, Nomikos P (1997) Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery 40:713–722CrossRefPubMed Honegger J, Fahlbusch R, Bornemann A, Hensen J, Buchfelder M, Müller M, Nomikos P (1997) Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery 40:713–722CrossRefPubMed
25.
Zurück zum Zitat Miyake I, Takeuchi Y, Kuramoto T, Kaku H, Nakayama H, Takata K, Kurita Y, Shigemori M, Hiromatsu Y, Yamada K (2006) Autoimmune hypophysitis treated with intravenous glucocorticoid therapy. Intern Med 45:1249–1252CrossRefPubMed Miyake I, Takeuchi Y, Kuramoto T, Kaku H, Nakayama H, Takata K, Kurita Y, Shigemori M, Hiromatsu Y, Yamada K (2006) Autoimmune hypophysitis treated with intravenous glucocorticoid therapy. Intern Med 45:1249–1252CrossRefPubMed
26.
Zurück zum Zitat Kristof RA, Van Roost D, Klingmuller D, Springer W, Schramm J (1999) Lymphocytic hypophysitis: non-invasive diagnosis and treatment by high dose methylprednisolone pulse therapy? J Neurol Neurosurg Psychiatry 67:398–402CrossRefPubMed Kristof RA, Van Roost D, Klingmuller D, Springer W, Schramm J (1999) Lymphocytic hypophysitis: non-invasive diagnosis and treatment by high dose methylprednisolone pulse therapy? J Neurol Neurosurg Psychiatry 67:398–402CrossRefPubMed
27.
Zurück zum Zitat Yamagami K, Yoshioka K, Sakai H, Fukumoto M, Yamakita T, Hosoi M, Ishii T, Sato T, Tanaka S, Fujii S (2003) Treatment of lymphocytic hypophysitis by high-dose methylprednisolone pulse therapy. Intern Med 42:168–173CrossRefPubMed Yamagami K, Yoshioka K, Sakai H, Fukumoto M, Yamakita T, Hosoi M, Ishii T, Sato T, Tanaka S, Fujii S (2003) Treatment of lymphocytic hypophysitis by high-dose methylprednisolone pulse therapy. Intern Med 42:168–173CrossRefPubMed
28.
Zurück zum Zitat Kristof RA, van Roost D, Schramm J, Wichers M (1998) Primary granulomatous hypophysitis not responsive to pulsed high dose prednisolone therapy: case report. J Neurol Neurosurg Psychiatry 64:693–694CrossRefPubMed Kristof RA, van Roost D, Schramm J, Wichers M (1998) Primary granulomatous hypophysitis not responsive to pulsed high dose prednisolone therapy: case report. J Neurol Neurosurg Psychiatry 64:693–694CrossRefPubMed
29.
Zurück zum Zitat Matta MP, Kany M, Delisle MB, Lagarrigue J, Caron PH (2002) A relapsing remitting lymphocytic hypophysitis. Pituitary 5:37–44CrossRefPubMed Matta MP, Kany M, Delisle MB, Lagarrigue J, Caron PH (2002) A relapsing remitting lymphocytic hypophysitis. Pituitary 5:37–44CrossRefPubMed
30.
Zurück zum Zitat Selch MT, DeSalles AA, Kelly DF, Frighetto L, Vinters HV, Cabatan-Awang C, Wallace RE, Solberg TD (2003) Stereotactic radiotherapy for the treatment of lymphocytic hypophysitis. Report of two cases. J Neurosurg 99:591–596CrossRefPubMed Selch MT, DeSalles AA, Kelly DF, Frighetto L, Vinters HV, Cabatan-Awang C, Wallace RE, Solberg TD (2003) Stereotactic radiotherapy for the treatment of lymphocytic hypophysitis. Report of two cases. J Neurosurg 99:591–596CrossRefPubMed
31.
Zurück zum Zitat Ray DK, Yen CP, Vance ML, Laws ER, Lopes B, Sheehan JP (2010) Gamma knife surgery for lymphocytic hypophysitis. J Neurosurg 112:118–121CrossRefPubMed Ray DK, Yen CP, Vance ML, Laws ER, Lopes B, Sheehan JP (2010) Gamma knife surgery for lymphocytic hypophysitis. J Neurosurg 112:118–121CrossRefPubMed
32.
Zurück zum Zitat Castor CW, Bull FE (1985) Review of United States data on neoplasms in rheumatoid arthritis. Am J Med 78:33–38CrossRefPubMed Castor CW, Bull FE (1985) Review of United States data on neoplasms in rheumatoid arthritis. Am J Med 78:33–38CrossRefPubMed
33.
Zurück zum Zitat Singh G, Fries JF, Spitz P, Williams CA (1989) Toxic effects of azathioprine in rheumatoid arthritis. A national post-marketing perspective. Arthritis Rheum 32:837–843CrossRefPubMed Singh G, Fries JF, Spitz P, Williams CA (1989) Toxic effects of azathioprine in rheumatoid arthritis. A national post-marketing perspective. Arthritis Rheum 32:837–843CrossRefPubMed
34.
Zurück zum Zitat Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD (2005) Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 54:1121–1125CrossRefPubMed Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD (2005) Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 54:1121–1125CrossRefPubMed
35.
Zurück zum Zitat Birkeland SA, Hamilton-Dutoit S (2003) Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? Transplantation 76:984–988CrossRefPubMed Birkeland SA, Hamilton-Dutoit S (2003) Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? Transplantation 76:984–988CrossRefPubMed
36.
Zurück zum Zitat Curtò L, Torre ML, Cotta OR, Losa M, Terreni MR, Santarpia L, Trimarchi F, Cannavò S (2010) Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities–report of a case and literature review. ScientificWorldJournal 10:126–134PubMed Curtò L, Torre ML, Cotta OR, Losa M, Terreni MR, Santarpia L, Trimarchi F, Cannavò S (2010) Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities–report of a case and literature review. ScientificWorldJournal 10:126–134PubMed
Metadaten
Titel
Azathioprine as an alternative treatment in primary hypophysitis
verfasst von
L. Papanastasiou
T. Pappa
V. Tsiavos
E. Tseniklidi
I. Androulakis
G. Kontogeorgos
G. Piaditis
Publikationsdatum
01.03.2011
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 1/2011
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-010-0252-5

Weitere Artikel der Ausgabe 1/2011

Pituitary 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.